Aimee Talleur, MD
Aimee C. Talleur, MD

Aimee C. Talleur, MD

Instructor, St. Jude Faculty

  • Associate Director, BMTCT Fellowship Program



MD - State University of New York Upstate Medical University, Syracuse, NY
- Union College, Schenectady, NY

Research Interests

  • Immunotherapy and cellular therapy for solid tumors
  • Chimeric antigen receptor therapy

Selected Publications

Talleur AC, Triplett BM, Federico S, Mamcarz E, Janssen W, Wu J, Shook D, Leung W, Furman WL. Consolidation therapy for newly diagnosed pediatric high-risk neuroblastoma patients using busulfan/melphalan, autologous hematopoietic cell transplant, anti-GD2 antibody, GM-CSF, IL-2 and haploidentical NK cells. Biol Blood Marrow Transplant Nov;23(11):1910-1917, 2017.

Snaman JM, Talleur AC, Lu J, Levine DR, Kaye EC, Sykes A, Lu Z, Triplett BM, Baker JN. Treatment intensity and symptom burden in hospitalized adolescent and young adult hematopoietic cell transplant recipients at the end of life. Bone Marrow Transplant Nov 13, 2017.

Talleur A, Navid F, Spunt SL, McCarville MB, Wu J, Mao S, Davidoff AM, Neel M,  Krasin MJ. Limited Margin Radiotherapy for Children and Young Adults with Ewing Sarcoma Achieves High Rates of Local Tumor Control. The International Journal of Radiation Oncology Biology and Physics Sept;96(1):119-126, 2016. doi:10.1016/j.ijrobp.2016.04.001

Last update: December 2017